RocheDiabetes Health Connection - Let's Talk Numbers

Better for employees. Better for employers.

Watch how you can help employees with diabetes feel their best while controlling costs for your business.

Presenting customized, all-in-one diabetes support and remote monitoring

Population Management

Aggregated data from the entire patient population drives risk stratification.

Member Engagement

Includes the mySugr App, an Accu-Chek® Guide Me meter and unlimited test strips delivered at home.

Certified Coaching

Our Certified Diabetes Educators® work with your employees to set goals and improve outcomes.

Device Integration

Connects easily with most popular diabetes and health monitoring devices.

Better control translates to lower costs

1.48%

Estimated HbA1c reduction

Participation in the mySugr program has been associated with significant reductions in estimated HbA1c at 16 weeks in patients with uncontrolled diabetes.¹

Up to $2,500

Lower healthcare costs for patients with uncontrolled diabetes following improved glycemic control^1,2

It has also been shown that improving glycemic control can lower healthcare costs by up to $2,500 per patient in the first year following improvement.^1,2

Ready to learn more?

Request a 15-minute demonstration.

First Name *

Last Name *

Job Title *

Role *

Email *

Phone

Company *

Company Location *

Employees/Covered Lives *

By checking this box, in addition to the 15-minute demonstration, I would like to receive email communications from Roche Diabetes Care, Inc. (“Roche”) or persons or contractors acting on Roche's behalf about Roche products or services at the email address I have provided.

For information about how your personal information is used, visit our Privacy Policy

Leave this field blank

1 Bankosegger R, Kober J, Mayer H. Sustainable improvement in quality of blood glucose control in users of mySugr's integrated diabetes management. mySugr 2019. Available at: https://assets.mysugr.com/website/mysugr.com-wordpress/uploads/2019/06/a.... Accessed August 16, 2019.

2 Bansal, Megha, et al. “Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes.” Applied Health Economics and Health Policy, vol. 16, 23 June 2018, pp. 675–684., doi:https://link.springer.com/article/10.1007%2Fs40258-018-0398-2.

3 Roche Diabetes Care, Inc., the maker of Accu-Chek products, communicates with customers to provide information on advances in diagnosis and healthcare, product innovations, and special offers. Roche does not provide your personal information to any third party without your permission, except Roche affiliates and business working on our behalf. You may always opt out of future marketing communications by calling 1-800-858-8072 or contacting us at accu-chek.care@roche.com. If you wish to unsubscribe from email communications, you may also click the unsubscribe link in any email you receive from us.